Accuray Incorporated (0H8I.L)
USD 1.47
(2.4%)
USD 1.47
(2.4%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 103.58 Million USD | 23.51% |
| 2022 | 115.11 Million USD | 4.13% |
| 2021 | 110.54 Million USD | 34.03% |
| 2020 | 82.47 Million USD | -27.09% |
| 2019 | 113.13 Million USD | 55.34% |
| 2018 | 72.82 Million USD | 90.83% |
| 2017 | 38.16 Million USD | -52.09% |
| 2016 | 79.65 Million USD | -11.24% |
| 2015 | 89.75 Million USD | -25.27% |
| 2014 | 120.1 Million USD | 16.31% |
| 2013 | 103.26 Million USD | -17.69% |
| 2012 | 125.45 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 FY | 141.69 Million USD | 23.09% |
| 2023 Q1 | 127.46 Million USD | 10.73% |
| 2023 Q2 | 128.98 Million USD | 1.19% |
| 2023 Q3 | 145.86 Million USD | 13.09% |
| 2023 Q4 | 103.58 Million USD | -2.53% |
| 2022 Q3 | 115.77 Million USD | -16.99% |
| 2022 Q4 | 115.11 Million USD | -0.57% |
| 2022 Q1 | 124.1 Million USD | 12.26% |
| 2022 Q2 | 139.46 Million USD | 12.38% |
| 2022 FY | 115.11 Million USD | 4.13% |
| 2021 Q3 | 103.48 Million USD | 28.27% |
| 2021 FY | 110.54 Million USD | 34.03% |
| 2021 Q1 | 116.72 Million USD | 41.52% |
| 2021 Q2 | 80.67 Million USD | -30.88% |
| 2021 Q4 | 110.54 Million USD | 6.83% |
| 2020 Q4 | 82.47 Million USD | 9.12% |
| 2020 Q2 | 94.25 Million USD | -16.09% |
| 2020 Q1 | 112.32 Million USD | 6.06% |
| 2020 Q3 | 75.58 Million USD | -19.81% |
| 2020 FY | 82.47 Million USD | -27.09% |
| 2019 Q2 | 114.61 Million USD | -13.89% |
| 2019 FY | 113.13 Million USD | 55.34% |
| 2019 Q4 | 105.9 Million USD | -16.48% |
| 2019 Q3 | 126.8 Million USD | 10.64% |
| 2019 Q1 | 133.09 Million USD | 60.27% |
| 2018 Q2 | 77.39 Million USD | 28.18% |
| 2018 Q1 | 60.38 Million USD | 25.81% |
| 2018 FY | 72.82 Million USD | 90.83% |
| 2018 Q4 | 83.04 Million USD | -0.48% |
| 2018 Q3 | 83.44 Million USD | 7.82% |
| 2017 Q1 | 90.1 Million USD | -2.58% |
| 2017 Q4 | 47.99 Million USD | -24.93% |
| 2017 FY | 38.16 Million USD | -52.09% |
| 2017 Q3 | 63.92 Million USD | -29.26% |
| 2017 Q2 | 90.36 Million USD | 0.29% |
| 2016 Q1 | 91.4 Million USD | 0.85% |
| 2016 Q4 | 92.48 Million USD | -15.82% |
| 2016 FY | 79.65 Million USD | -11.24% |
| 2016 Q3 | 109.86 Million USD | 9.11% |
| 2016 Q2 | 100.69 Million USD | 10.16% |
| 2015 FY | 89.75 Million USD | -25.27% |
| 2015 Q4 | 90.64 Million USD | -30.55% |
| 2015 Q3 | 130.51 Million USD | 10.35% |
| 2015 Q2 | 118.27 Million USD | -0.77% |
| 2015 Q1 | 119.18 Million USD | -0.76% |
| 2014 Q1 | 90.07 Million USD | -12.77% |
| 2014 Q2 | 101.87 Million USD | 13.1% |
| 2014 Q4 | 120.1 Million USD | 13.8% |
| 2014 Q3 | 105.54 Million USD | 3.59% |
| 2014 FY | 120.1 Million USD | 16.31% |
| 2013 Q2 | 130.63 Million USD | -4.98% |
| 2013 Q3 | 114.27 Million USD | -12.52% |
| 2013 Q4 | 103.26 Million USD | -9.63% |
| 2013 FY | 103.26 Million USD | -17.69% |
| 2013 Q1 | 137.48 Million USD | 9.59% |
| 2012 Q4 | 125.45 Million USD | 677.68% |
| 2012 FY | 125.45 Million USD | 0.0% |
| 2012 Q2 | -94.77 Million USD | 0.0% |
| 2012 Q3 | 16.13 Million USD | 117.02% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Phreesia, Inc. | -75.53 Million USD | 237.133% |
| Align Technology, Inc. | -840.47 Million USD | 112.325% |
| Elevance Health Inc. | 18.59 Billion USD | 99.443% |
| AxoGen, Inc. | 32.26 Million USD | -221.038% |
| Boston Scientific Corporation | 8.23 Billion USD | 98.742% |
| CVS Health Corporation | 71.18 Billion USD | 99.854% |
| Cardinal Health, Inc. | 476 Million USD | 78.238% |
| Centene Corporation | 506 Million USD | 79.528% |
| DaVita Inc. | 10.65 Billion USD | 99.028% |
| HCA Healthcare, Inc. | 40.92 Billion USD | 99.747% |
| Hologic, Inc. | 374.4 Million USD | 72.333% |
| Humana Inc. | 5.51 Billion USD | 98.123% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | 79.029% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | 98.088% |
| Masimo Corporation | 804 Million USD | 87.116% |
| McKesson Corporation | 889 Million USD | 88.348% |
| Patterson Companies, Inc. | 648.47 Million USD | 84.026% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | 97.788% |
| ResMed Inc. | 635.57 Million USD | 83.702% |
| Henry Schein, Inc. | 2.57 Billion USD | 95.969% |
| Teladoc Health, Inc. | 468.6 Million USD | 77.895% |
| Universal Health Services, Inc. | 5.24 Billion USD | 98.026% |
| Veeva Systems Inc. | -647.71 Million USD | 115.993% |
| Baxter International Inc. | 11.16 Billion USD | 99.072% |
| Becton, Dickinson and Company | 14.46 Billion USD | 99.284% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 103.894% |
| Danaher Corporation | 13.49 Billion USD | 99.232% |
| Stryker Corporation | 10.02 Billion USD | 98.967% |
| Medtronic plc | 23.67 Billion USD | 99.563% |